Literature DB >> 10579361

Activation of growth hormone receptor delivers an antiapoptotic signal: evidence for a role of Akt in this pathway.

J A Costoya1, J Finidori, S Moutoussamy, R Seãris, J Devesa, V M Arce.   

Abstract

A signaling pathway was delineated by which GH promotes cell survival. Experiments were performed in human leukemic cells (HL-60) and Chinese hamster ovary (CHO) cells. In HL-60 cells, GH treatment reduced starvation-induced cell death. In contrast, when HL-60 cells were treated with an anti-GH antibody, cell survival was sharply reduced. In CHO cells stably expressing either the wild-type (wtGHR) or a truncated form (delta454GHR) of the GH receptor in which GH induces a sustained activation of the receptor-associated tyrosine kinase JAK2, we found that GH stimulation inhibited programmed cell death induced by withdrawal of survival factors. This effect was enhanced in cells expressing the truncated form. In contrast, GH did not affect cell survival in CHO cells transfected with either the empty vector or a mutated GHR unable to transduce the signal (4P/AGHR). We also showed that the inhibitory action of GH on apoptosis is probably mediated via stimulation of the serine-threonine kinase Akt, as 1) GH treatment induces a prompt phosphorylation of Akt; and 2) GH effects on cell survival are abolished by transfection of an Akt mutant that exhibits dominant negative function. Experiments with pharmacological inhibitors demonstrated that GH-induced Akt phosphorylation is dependent on phosphoinositide 3-kinase activation. In contrast, we found no changes in Bcl-2 levels secondary to GHR activation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10579361     DOI: 10.1210/endo.140.12.7209

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  24 in total

1.  Osteoblast-restricted Disruption of the Growth Hormone Receptor in Mice Results in Sexually Dimorphic Skeletal Phenotypes.

Authors:  Vandana Singhal; Brian C Goh; Mary L Bouxsein; Marie-Claude Faugere; Douglas J DiGirolamo
Journal:  Bone Res       Date:  2013-03-29       Impact factor: 13.567

2.  Proteolytic processing of human growth hormone (GH) by rat tissues in vitro: influence of sex and age.

Authors:  M Garcia-Barros; J Devesa; V M Arce
Journal:  J Endocrinol Invest       Date:  2000-12       Impact factor: 4.256

3.  Erbb2 regulates inflammation and proliferation in the skin after ultraviolet irradiation.

Authors:  Justin G Madson; David T Lynch; Kelsey L Tinkum; Sumanth K Putta; Laura A Hansen
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

4.  Nuclear factor-kappaB (NF-kappaB) p65 interacts with Stat5b in growth plate chondrocytes and mediates the effects of growth hormone on chondrogenesis and on the expression of insulin-like growth factor-1 and bone morphogenetic protein-2.

Authors:  Shufang Wu; Allison Morrison; Hongzhi Sun; Francesco De Luca
Journal:  J Biol Chem       Date:  2011-05-18       Impact factor: 5.157

Review 5.  Acromegaly: re-thinking the cancer risk.

Authors:  Siobhan Loeper; Shereen Ezzat
Journal:  Rev Endocr Metab Disord       Date:  2008-03       Impact factor: 6.514

6.  Effects of recombinant growth hormone replacement and physical rehabilitation in recovery of gross motor function in children with cerebral palsy.

Authors:  Pedro Reimunde; Cristina Rodicio; Natalia López; Alba Alonso; Pablo Devesa; Jesús Devesa
Journal:  Ther Clin Risk Manag       Date:  2010-11-30       Impact factor: 2.423

Review 7.  Modulation of growth hormone receptor abundance and function: roles for the ubiquitin-proteasome system.

Authors:  Stuart J Frank; Serge Y Fuchs
Journal:  Biochim Biophys Acta       Date:  2008-06-09

8.  Reduced susceptibility to azoxymethane-induced aberrant crypt foci formation and colon cancer in growth hormone deficient rats.

Authors:  Robert E Carroll; Robert A Goodlad; Aleksandra J Poole; Angela L Tyner; R Brooks Robey; Steven M Swanson; Terry G Unterman
Journal:  Growth Horm IGF Res       Date:  2009-04-29       Impact factor: 2.372

9.  Comparison of pulsatile vs. continuous administration of human placental growth hormone in female C57BL/6J mice.

Authors:  Shutan Liao; Mark H Vickers; Angharad Evans; Joanna L Stanley; Philip N Baker; Jo K Perry
Journal:  Endocrine       Date:  2016-08-11       Impact factor: 3.633

10.  Interruption of growth hormone signaling via SHC and ERK in 3T3-F442A preadipocytes upon knockdown of insulin receptor substrate-1.

Authors:  Xiangdong Wang; Ning Yang; Luqin Deng; Xin Li; Jing Jiang; Yujun Gan; Stuart J Frank
Journal:  Mol Endocrinol       Date:  2009-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.